<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font24">the </span>
   <span class="font16">for </span>
   <span class="font14">The </span>
   <span class="font14">with </span>
   <span class="font14">are </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">COVID- </span>
   <span class="font13">patients </span>
   <span class="font12">[]. </span>
   <span class="font12">clinical </span>
   <span class="font12">were </span>
   <span class="font12">{background </span>
   <span class="font12">vaccines </span>
   <span class="font12">was </span>
   <span class="font12">against </span>
   <span class="font12">that </span>
   <span class="font12">vaccine </span>
   <span class="font11">have </span>
   <span class="font11">this </span>
   <span class="font11">drug </span>
   <span class="font11">has </span>
   <span class="font11">margin </span>
   <span class="font11">{border-style </span>
   <span class="font11">also </span>
   <span class="font11">study </span>
   <span class="font11">treatment </span>
   <span class="font11">HCQ </span>
   <span class="font11">from </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">day </span>
   <span class="font11">viral </span>
   <span class="font11">virus </span>
   <span class="font11">coronavirus </span>
   <span class="font11">spike </span>
   <span class="font11">therapeutic </span>
   <span class="font11">infection </span>
   <span class="font11">into </span>
   <span class="font11">Health </span>
   <span class="font11">However, </span>
   <span class="font11">University </span>
   <span class="font11">disease </span>
   <span class="font11">therapy </span>
   <span class="font11">may </span>
   <span class="font11">phase </span>
   <span class="font10">Ebola </span>
   <span class="font10">Med </span>
   <span class="font10">RNA </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">This </span>
   <span class="font10">favipiravir </span>
   <span class="font10">novel </span>
   <span class="font10">respiratory </span>
   <span class="font10">vector </span>
   <span class="font10">developing </span>
   <span class="font10">dosage </span>
   <span class="font10">given </span>
   <span class="font10">influenza </span>
   <span class="font10">its </span>
   <span class="font10">lopinavir </span>
   <span class="font10">pre-clinical </span>
   <span class="font10">protein </span>
   <span class="font10">severe </span>
   <span class="font10">shown </span>
   <span class="font10">stage. </span>
   <span class="font10">these </span>
   <span class="font10">trials </span>
   <span class="font10">used </span>
   <span class="font10">activity </span>
   <span class="font10">can </span>
   <span class="font10">cell </span>
   <span class="font10">had </span>
   <span class="font10">individuals </span>
   <span class="font10">Pre-clinical </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">TCZ </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">[], </span>
   <span class="font10">but </span>
   <span class="font10">combination </span>
   <span class="font10">dose </span>
   <span class="font10">efficacy </span>
   <span class="font10">group </span>
   <span class="font10">host </span>
   <span class="font10">protease </span>
   <span class="font10">px; </span>
   <span class="font10">replication </span>
   <span class="font10">response </span>
   <span class="font10">ritonavir </span>
   <span class="font10">such </span>
   <span class="font10">twice </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">HIV </span>
   <span class="font10">both </span>
   <span class="font10">cells </span>
   <span class="font10">days. </span>
   <span class="font10">developed </span>
   <span class="font10">font-size </span>
   <span class="font10">immune </span>
   <span class="font10">inhibitor </span>
   <span class="font10">proteins </span>
   <span class="font10">randomized </span>
   <span class="font10">ribavirin </span>
   <span class="font10">syndrome </span>
   <span class="font10">there </span>
   <span class="font10">trial </span>
   <span class="font10">who </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Center, </span>
   <span class="font10">China </span>
   <span class="font10">DNA </span>
   <span class="font10">al. </span>
   <span class="font10">been </span>
   <span class="font10">causes </span>
   <span class="font10">double; </span>
   <span class="font10">drugs </span>
   <span class="font10">first </span>
   <span class="font10">grid.. </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">hypertension, </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">molecules </span>
   <span class="font10">patients. </span>
   <span class="font10">polymerase </span>
   <span class="font10">under </span>
   <span class="font10">vaccines. </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Currently, </span>
   <span class="font10">IL- </span>
   <span class="font10">Institute </span>
   <span class="font10">Oral </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Research </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Sciences </span>
   <span class="font10">Tech </span>
   <span class="font10">Texas </span>
   <span class="font10">There </span>
   <span class="font10">Vaccines </span>
   <span class="font10">Zika, </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">antibody </span>
   <span class="font10">any </span>
   <span class="font10">attenuated </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">conducted </span>
   <span class="font10">days </span>
   <span class="font10">did </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">health </span>
   <span class="font10">high </span>
   <span class="font10">new </span>
   <span class="font10">patient </span>
   <span class="font10">pneumonia </span>
   <span class="font10">production </span>
   <span class="font10">proteins, </span>
   <span class="font10">rate </span>
   <span class="font10">recombinant </span>
   <span class="font10">review </span>
   <span class="font10">solid; </span>
   <span class="font10">treated </span>
   <span class="font10">trial. </span>
   <span class="font10">type </span>
   <span class="font10">vaccine. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(Figs. </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(whole </span>
   <span class="font10">... </span>
   <span class="font10">ACE </span>
   <span class="font10">ACE- </span>
   <span class="font10">BID </span>
   <span class="font10">COVID-. </span>
   <span class="font10">DM, </span>
   <span class="font10">Drug </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">Inc. </span>
   <span class="font10">Infect </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Non-replicating </span>
   <span class="font10">RAG, </span>
   <span class="font10">RCT </span>
   <span class="font10">Vaccine </span>
   <span class="font10">advantages </span>
   <span class="font10">adverse </span>
   <span class="font10">after </span>
   <span class="font10">antiviral </span>
   <span class="font10">arthritis, </span>
   <span class="font10">azithromycin </span>
   <span class="font10">being </span>
   <span class="font10">benefits </span>
   <span class="font10">bold </span>
   <span class="font10">chloroquine </span>
   <span class="font10">control </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">darunavir </span>
   <span class="font10">development </span>
   <span class="font10">different </span>
   <span class="font10">disease. </span>
   <span class="font10">doses </span>
   <span class="font10">during </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">endosomal </span>
   <span class="font10">envelope </span>
   <span class="font10">every </span>
   <span class="font10">genome </span>
   <span class="font10">groups </span>
   <span class="font10">help </span>
   <span class="font10">like </span>
   <span class="font10">live </span>
   <span class="font10">liver </span>
   <span class="font10">loading </span>
   <span class="font10">low </span>
   <span class="font10">lysosomal </span>
   <span class="font10">medRxiv </span>
   <span class="font10">more </span>
   <span class="font10">multiple </span>
   <span class="font10">neutralizing </span>
   <span class="font10">orally </span>
   <span class="font10">pandemic </span>
   <span class="font10">patients, </span>
   <span class="font10">per </span>
   <span class="font10">prevents </span>
   <span class="font10">producing </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor </span>
   <span class="font10">renal </span>
   <span class="font10">responses </span>
   <span class="font10">results </span>
   <span class="font10">systemic </span>
   <span class="font10">tablets </span>
   <span class="font10">through </span>
   <span class="font10">via </span>
   <span class="font10">will </span>
   <span class="font10">xue </span>
  </p>
 </body>
</html>
